Machine Learning Scientist - Computational Biology (Multiple Levels)

About Us Deep Genomics is at the forefront of using artificial intelligence to transform drug discovery. Our proprietary AI platform decodes the complexity of genome biology to identify novel drug targets, mechanisms, and therapeutics inaccessible through traditional methods. With expertise spanning machine learning, bioinformatics, data science, engineering, and drug development, our multidisciplinary team in Toronto and Cambridge, MA is revolutionizing how new medicines are created. Where You Fit In We are seeking a Machine Learning Scientist to help expand our AI workbench for drug discovery. Pioneered by our company, the application of machine learning and AI to drug discovery is a rapidly advancing field with many unsolved and exciting challenges. Whether you're an early-career researcher or a seasoned expert, you will work with an interdisciplinary team of scientists and engineers to develop state-of-the-art machine learning models to decode nucleic acid and protein-level mechanisms, analyze large biological datasets, and support the design of therapeutic molecules. This is an opportunity to work at the interface of machine learning and computational biology, making impactful contributions to drug discovery and therapeutic development. Key Responsibilities Develop and implement advanced machine learning models for RNA biology, systems biology, and structural biology to solve frontier challenges in drug discovery. Collaborate with cross-functional teams (e.g., ML engineering, target discovery, and experimental biology) to drive research projects that identify novel drug targets and preclinical candidates. Design and execute computational and experimental studies to validate and improve model predictions. Stay informed about the latest advancements in machine learning and computational biology, and apply them to real-world challenges. Share research findings through presentations, publications, and technical discussions.

Deep Genomics is at the forefront of using artificial intelligence to transform drug discovery. Our proprietary AI platform decodes the complexity of genome biology to identify novel drug targets, mechanisms, and therapeutics inaccessible through traditional methods. With expertise spanning machine learning, bioinformatics, data science, engineering, and drug development, our multidisciplinary team in Toronto and Cambridge, MA is revolutionizing how new medicines are created.